Bleeding disorders:

Indications for: Aminocaproic Acid Injection

Bleeding associated with fibrinolysis.

Adult Dosage:

4–5g (in 250mL of diluent) by IV infusion during the 1st hour, then 1g/hour (in 50mL of diluent) for 8 hours or until bleeding is controlled.

Children Dosage:

Not recommended.

Aminocaproic Acid Injection Contraindications:

Active intravascular clotting process. Disseminated intravascular coagulation without concomitant heparin.

Aminocaproic Acid Injection Warnings/Precautions:

Upper urinary tract bleeding: not recommended. Cardiac, hepatic or renal disease. Risk of myopathy with long-term use; monitor creatine phosphokinase (CPK); discontinue if CPK rises. Avoid rapid IV administration. Neonates. Pregnancy (Cat.C). Nursing mothers.

Aminocaproic Acid Injection Classification:


Aminocaproic Acid Injection Interactions:

Avoid concomitant Factor IX complex or Anti-inhibitor Coagulant concentrates; may increase thrombosis risk.

Adverse Reactions:

Inj site reactions, bradycardia, hypotension, GI upset, edema, headache, malaise, CNS effects, thrombosis, others; rare: myopathy.


Formerly known under the brand name Amicar.

How Supplied:

Contact supplier